Healx Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
69
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2M
- Investors
-
26
Healx General Information
Description
Developer of an artificial intelligence-driven drug discovery technology designed to create treatments for rare diseases. The company offers a combination of frontier machine learning technology and drug discovery expertise, enabling clients to accelerate the development of novel treatments and improve the success rate for addressing the unmet needs of rare disease patients worldwide.
Contact Information
Website
www.healx.aiCorporate Office
- 3rd Floor Charter House
- 66-68 Hills Road
- Cambridge CB2 1LA
- England, United Kingdom
Corporate Office
- 3rd Floor Charter House
- 66-68 Hills Road
- Cambridge CB2 1LA
- England, United Kingdom
Healx Timeline
Healx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 15-Jul-2025 | $2M | Completed | Clinical Trials - Phase 1 | ||
| 7. Later Stage VC (Series C) | 01-Aug-2024 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC (Series B) | 16-Oct-2019 | Completed | Clinical Trials - General | |||
| 5. Early Stage VC (Series A) | 26-Jul-2018 | Completed | Clinical Trials - General | |||
| 4. Early Stage VC (Series A) | 05-Oct-2016 | Completed | Clinical Trials - General | |||
| 3. Seed Round | 30-Jun-2015 | Completed | Clinical Trials - General | |||
| 2. Accelerator/Incubator | 01-Jan-2015 | Completed | Clinical Trials - General | |||
| 1. University Spin-Out | 30-Apr-2014 | Completed | Startup |
Healx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C Preferred | ||||||||
| Series B | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Series B | ||||||||
| Series A Ordinary | ||||||||
| Series A Preferred | 5,786,577 | $0.000000 | $1.5 | $1.5 | $1.5 | 14.22% | ||
| Ordinary | 2,878,000 | $0.000000 | $0.67 | $0.67 | $0.67 | 7.07% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Healx Comparisons
Industry
Financing
Details
Healx Competitors (28)
One of Healx’s 28 competitors is Xaira Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xaira Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| Verge Labs | Venture Capital-Backed | San Francisco, CA | ||||
| Aitia | Venture Capital-Backed | Cambridge, MA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| Onyx | Venture Capital-Backed | Berkeley, CA |
Healx Patents
Healx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202509495-D0 | Medical use | Pending | 16-Jun-2025 | ||
| GB-202509498-D0 | Medical use | Pending | 16-Jun-2025 | ||
| GB-202509499-D0 | Medical use | Pending | 16-Jun-2025 | ||
| GB-202509233-D0 | Treatment | Pending | 11-Jun-2025 | ||
| GB-202507490-D0 | Treatment | Inactive | 15-May-2025 |
Healx Signals
Healx Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 333VC | Venture Capital | Minority | ||
| Mandashi | Venture Capital | Minority | ||
| SCI Ventures (London) | Venture Capital | Minority | ||
| 2468 Ventures | Venture Capital | Minority | ||
| AstraZeneca | Corporation | Minority |
Healx Acquisitions (2)
Healx’s most recent deal was a Merger/Acquisition with Vuja De Sciences. The deal was made on 28-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vuja De Sciences | 28-Jul-2025 | Merger/Acquisition | Drug Discovery | ||
| Nowomics | 19-Aug-2017 | Merger/Acquisition | Business/Productivity Software |
Healx FAQs
-
When was Healx founded?
Healx was founded in 2014.
-
Where is Healx headquartered?
Healx is headquartered in Cambridge, United Kingdom.
-
What is the size of Healx?
Healx has 69 total employees.
-
What industry is Healx in?
Healx’s primary industry is Discovery Tools (Healthcare).
-
Is Healx a private or public company?
Healx is a Private company.
-
What is Healx’s current revenue?
The current revenue for Healx is .
-
How much funding has Healx raised over time?
Healx has raised $134M.
-
Who are Healx’s investors?
333VC, Mandashi, SCI Ventures (London), 2468 Ventures, and AstraZeneca are 5 of 26 investors who have invested in Healx.
-
Who are Healx’s competitors?
Xaira Therapeutics, Verge Labs, Aitia, Exscientia, and Onyx are some of the 28 competitors of Healx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process